• LAST PRICE
    0.0003
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0003 / 0.0003
  • Day Range
    Low 0.0003
    High 0.0003
  • 52 Week Range
    Low 0.0002
    High 0.2350
  • Volume
    88,252
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.0003
TimeVolumeHDVY
09:32 ET115000.0003
12:03 ET417000.0003
12:10 ET350520.0003
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHDVY
Health Discovery Corp
123.5K
0.0x
---
United StatesARNI
Arno Therapeutics Inc
103.6K
0.0x
---
United StatesMLPH
Molecular Pharmacology (USA) Ltd
78.1K
-0.7x
---
United StatesVOQP
Vioquest Pharmaceuticals Inc
43.1K
0.0x
---
United StatesFPMI
FluoroPharma Medical Inc
92.5K
0.0x
---
United StatesCLCS
Cell Source Inc
176.3K
0.0x
---
As of 2022-11-30

Company Information

Health Discovery Corporation (HDC) is an intellectual property development company that uses mathematical techniques to analyze data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the field of molecular diagnostics where such tools are used for scientific discovery. Its Support Vector Machine (SVM) assets in particular have applicability in various other fields. HDC's joint venture, SVM Capital, LLC (SVM Capital), applies SVM technology to the financial markets. The Company's principal asset is its intellectual property, which includes mathematical algorithms called SVM and Fractal Genomic Modeling (FGM), as well as biomarkers that the Company has developed by applying its SVM and FGM techniques to genetic and proteomic data. It also owns the assets of Fractal Genomics, LLC, a company with FGM software. The FGM data analysis technique enables the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases.

Contact Information

Headquarters
2002 SUMMIT BLVD NE, SUITE 300ATLANTA, GA, United States 30319
Phone
404-566-4865
Fax
678-550-9107

Executives

Chairman of the Board, Chief Executive Officer
George McGovern
Senior Vice President - Computational Medicine
Hong Zhang
Vice President - Product Development
Mark Moore
Director
William Fromholzer
Director
Colleen Hutchinson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$123.5K
Revenue (TTM)
$0.00
Shares Outstanding
411.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.52
EPS
$-0.01
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.